Icare USA, a subsidiary of Icare Finland, recently announced the Icare® HOME tonometer has been cleared by the U.S. FDA and is now available for use in the United States.
The Icare® HOME device, which received CE Marking in 2014, is used by eye care professionals to monitor how patients' intraocular pressure (IOP) fluctuates throughout the day. The device reportedly uses the same patented technology in other Icare tonometers and requires no specialized skills for patient use. The unit features built-in Icare EyeSmart technology that performs automatic OD/OS recognition, and red and green light signs to help patients correctly position the tonometer.
Click here to read the full press release.
Like what you read? Follow OphthalmologyWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.